Pursuant to the provisions of Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026, Torrent Pharmaceuticals has informed that Crisil ESG Ratings & Analytics Limited, a SEBI registered ESG Rating Provider (Crisil ESG Ratings), has independently assigned the rating of ‘Crisil ESG 66’ and the Core ESG rating of ‘Crisil Core ESG 74’.
The above information is a part of company’s filings submitted to BSE.